Ramathibodi Hospital

mahidol.ac.th

Total trials

63

Active

5

Phase 3

6

Total enrollment

16,325

Read this sponsor's pipeline like an analyst.

Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.

~15-30 sec · cached for 24h

Pipeline matrix

Showing 7 of 7 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
Tranexamic Acid1
Normal Saline Solution1
Lidocaine1
Combined Intra-operative platelet-rich plasma with corticosteroid1
Intra-operative corticosteroid1
PRP1
corticosteroid1

Next readouts

  • 2026-06-30
  • 2026-06-30
  • 2026-12-31

Top conditions

  • Vascular Calcification3
  • Sleep Apnea, Obstructive2
  • Respiratory Effort2
  • Lumbar Disc Herniation2
  • Anterior Cruciate Ligament Injuries2
  • Osteoarthritis, Knee2
  • Thyrotoxic Periodic Paralysis1
  • Lupus Nephritis1

Frequently asked questions about Ramathibodi Hospital

How many clinical trials does Ramathibodi Hospital have on ClinicalTrials.gov?
Ramathibodi Hospital is listed as the lead sponsor on 63 clinical trials in ClinicalTrials.gov, 5 of which are currently active (recruiting, enrolling, or ongoing).
How many of Ramathibodi Hospital's trials are in Phase 3?
6 of Ramathibodi Hospital's trials are in Phase 3, spread across 7 active drug programs.
What therapeutic areas does Ramathibodi Hospital focus on?
Ramathibodi Hospital's most-studied conditions on ClinicalTrials.gov are Vascular Calcification, Sleep Apnea, Obstructive, Respiratory Effort, Lumbar Disc Herniation, Anterior Cruciate Ligament Injuries.
When are Ramathibodi Hospital's next clinical trial readouts?
Ramathibodi Hospital has 3 upcoming primary-completion readouts tracked here; the soonest is “The Effect of Local Infiltration of Tranexamic Acid on Postoperative Blood Loss in Orthognathic Surgery”, expected around 2026-06-30.